AstraZeneca may have used outdated data during vaccine trial

New Delhi, 23/3 (AO Bureau):The Corona vaccine of the British-Swedish pharmaceutical company AstraZeneca has once again come under suspicion. The US Health Agency suspects that the company used old data during the trial. Let us know that the day before, AstraZeneca has announced the results of the vaccine trial in America. Under this, it has been said that his vaccine is 79% effective.

According to the US National Institute of Allergy and Infectious Disease, the Data Safety Monitoring Board has raised concerns about AstraZeneca’s data. The board suspects that AstraZeneca used old data during the trial. So it is difficult to tell exactly how effective this vaccine is. The final decision on the use of this vaccine in America will be made by an Advisory Committee.

79 percent effective
A large trial of the Oxford AstraZeneca vaccine in the US and South American countries has revealed that the vaccine is 79 percent effective at preventing Covid-19 and up to 100 percent effective at preventing the disease from becoming serious. The third phase of the vaccine, developed by Oxford University and the AstraZeneca Company, was studied in the US, Chile and Peru, confirming its “safe and effective”.

Comments are closed.